Clinical Trial Update: Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG [Phase 2]

View source ↗

Summary

Rohto Pharmaceutical is conducting a Phase 2 exploratory trial of ADR-002K in heart failure patients with ischemic heart disease undergoing CABG; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• ADR-002K

Snippet

Sponsor: Rohto Pharmaceutical Co., Ltd. | Conditions: Ischemic Heart Disease | Phase 2 | Status: NOT_YET_RECRUITING